210 related articles for article (PubMed ID: 6205768)
1. K562 cells induced to differentiate by phorbol ester tumor promotors resist NK lysis.
Dokhelar MC; Garson D; Wakasugi H; Tabilio A; Testa U; Vainchenker W; Tursz T
Cell Immunol; 1984 Sep; 87(2):389-99. PubMed ID: 6205768
[TBL] [Abstract][Full Text] [Related]
2. The effect of differentiation inducers on the sensitivity of two myeloid cell lines to natural killer (NK) cell-mediated lysis.
Golden M; Dempsey RA; Mier JW; Parkinson DR
Int J Immunopharmacol; 1983; 5(5):411-9. PubMed ID: 6197382
[TBL] [Abstract][Full Text] [Related]
3. Studies on the lethal hit stage of natural killer cell-mediated cytotoxicity. I. Both phorbol ester and ionophore are required for release of natural killer cytotoxic factors (NKCF), suggesting a role for protein kinase C activity.
Graves SS; Bramhall J; Bonavida B
J Immunol; 1986 Sep; 137(6):1977-84. PubMed ID: 2427588
[TBL] [Abstract][Full Text] [Related]
4. Influence of 12-O-tetradecanoylphorbol-13-acetate (TPA) on the susceptibility of K562 to natural cytotoxicity: evidence for clonal variation in differentiation-induced changes of lytic sensitivity.
Kimber I; Moore M; Harrison CJ
Int J Cancer; 1984 May; 33(5):693-700. PubMed ID: 6202648
[TBL] [Abstract][Full Text] [Related]
5. Correlation of murine susceptibility to tumor, parasite and bacterial challenge with altered cell-mediated immunity following systemic exposure to the tumor promoter phorbol myristate acetate.
Murray MJ; Lauer LD; Luster MI; Luebke RW; Adams DO; Dean JH
Int J Immunopharmacol; 1985; 7(4):491-500. PubMed ID: 3876295
[TBL] [Abstract][Full Text] [Related]
6. Tumour promoter-mediated reversible inhibition of cell-cell communication (electrical coupling). Relationship with phorbol ester binding and de novo macromolecule synthesis.
Yamasaki H; Enomoto T; Martel N; Shiba Y; Kanno Y
Exp Cell Res; 1983 Jul; 146(2):297-308. PubMed ID: 6192003
[TBL] [Abstract][Full Text] [Related]
7. Natural killing of tumor cells by human peripheral blood cells. Suppression of killing in vitro by tumor-promoting phorbol diesters.
Seaman WE; Gindhart TD; Blackman MA; Dalal B; Talal N; Werb Z
J Clin Invest; 1981 May; 67(5):1324-33. PubMed ID: 6939690
[TBL] [Abstract][Full Text] [Related]
8. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
Uchida A; Klein E
Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
[TBL] [Abstract][Full Text] [Related]
9. Suppression of the cytotoxic response of mouse lymphocytes to syngeneic tumor cells by tumor-promoting phorbol ester.
Fredrickson GG; Bennett M
Cancer Res; 1982 Sep; 42(9):3601-6. PubMed ID: 7105034
[TBL] [Abstract][Full Text] [Related]
10. Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation.
Koeffler HP; Bar-Eli M; Territo MC
Cancer Res; 1981 Mar; 41(3):919-26. PubMed ID: 6936077
[TBL] [Abstract][Full Text] [Related]
11. The isolation of natural killer (NK)-resistant variants of the K562 cell line by mutagenesis and selection with antibodies which inhibit NK cell-mediated lysis.
Werkmeister JA; Triglia T; Burns GF
Cell Immunol; 1985 Apr; 92(1):123-33. PubMed ID: 3865715
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of differentiation inducers on natural killer sensitivity of K 562 cells: Analysis at a single-cell level.
Garson D; Dokhelar MC; Vainchenker W; Tursz T
Cell Immunol; 1983 Jun; 78(2):400-6. PubMed ID: 6861208
[TBL] [Abstract][Full Text] [Related]
13. Tumor-promoting phorbol esters affect production of prolactin and growth hormone by rat pituitary cells.
Osborne R; Tashjian AH
Endocrinology; 1981 Apr; 108(4):1164-70. PubMed ID: 7472264
[TBL] [Abstract][Full Text] [Related]
14. Role of phorbol ester receptors in the 12-0-tetradecanoyl-phorbol-13-acetate (TPA)-induced down-regulation of colony-stimulating factor (CSF-1) binding to murine peritoneal exudate macrophages.
Chen BD; Wilkins KL
J Cell Physiol; 1985 Aug; 124(2):305-12. PubMed ID: 3876342
[TBL] [Abstract][Full Text] [Related]
15. Effects of protein kinase C (PK-C) activators and inhibitors on human large granular lymphocytes (LGL): role of PK-C on natural killer (NK) activity.
Procopio AD; Paolini R; Gismondi A; Piccoli M; Adamo S; Cavallo G; Frati L; Santoni A
Cell Immunol; 1989 Feb; 118(2):470-81. PubMed ID: 2910505
[TBL] [Abstract][Full Text] [Related]
16. Phorbolester-treated human lymphocytes are susceptible to natural killer cell-mediated cytolysis.
Kabelitz D; Kunkel HG
J Immunol; 1983 Jun; 130(6):2505-7. PubMed ID: 6189890
[TBL] [Abstract][Full Text] [Related]
17. Control of endogenous cell regulators by the second-stage tumor promoter phorbol-12-retinoate 13-acetate.
Simantov R; Marks F; Fürstenberger G; Sachs L
Int J Cancer; 1983 Apr; 31(4):497-500. PubMed ID: 6299980
[TBL] [Abstract][Full Text] [Related]
18. Modulation of natural killer sensitivity of murine trophoblast cells by tumor promoter and interferon.
Tanaka K; Chang KS
Int J Cancer; 1982 Mar; 29(3):315-21. PubMed ID: 6175591
[TBL] [Abstract][Full Text] [Related]
19. Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion.
Lotem J; Sachs L
Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5158-62. PubMed ID: 291929
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of terminal differentiation of hamster epidermal cells in culture by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate.
Sisskin EE; Barrett JC
Cancer Res; 1981 Feb; 41(2):593-603. PubMed ID: 7448806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]